Page 1 of Clinical Trials for Salmeterol Fluticasone propionate combination, 140 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Clinical Assessment Of GW815SF HFA MDI In Pediatric Patients With Bronchial Asthma
Last Updated: June 3, 2010
Condition(s): Bronchial Asthma
2
Completed
Pediatric Asthma Study Using Stepwise Treatment With Two Food And Drug Administration Approved Asthma Medications
Last Updated: October 9, 2008
Condition(s): Asthma
3
Completed
Airway Hyper-responsiveness Study In Asthma Using Salmeterol/Fluticasone Propionate Combination Product
Last Updated: March 17, 2011
Condition(s): Asthma
4
Recruiting
Study To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) Taking Salmeterol Xinafoate/Fluticasone Propionate Combination
Last Updated: May 22, 2012
Condition(s): Pulmonary Disease, Chronic Obstructive
5
Completed
Fluticasone and Salmeterol in Allergic Rhinitis
Last Updated: July 5, 2011
Condition(s): Allergic Rhinitis
6
Completed
SERETIDE 100/50 bd (Twice Daily) Versus FLIXOTIDE 100 bd As Initial Maintenance Therapy In Moderate Asthma In Adults
Last Updated: March 22, 2012
Condition(s): Asthma
7
Completed
SERETIDE 50/500mcg Versus Tiotropium Bromide On Exacerbation Rates In Severe Chronic Obstructive Pulmonary Disease
Last Updated: August 7, 2006
Condition(s): Chronic Obstructive Pulmonary Disease
8
Completed
A Long Term Prospective Follow Up Study For The CATO Study (SAS30018/SER9702)
Last Updated: March 15, 2012
Condition(s): Asthma
9
Completed
Clinical Assessment Of GW815SF Salmeterol/Fluticasone Propionate(HFA MDI) In Pediatric Patients With Bronchial Asthma -A Long Term (24-Week) Study-
Last Updated: June 18, 2009
Condition(s): Bronchial Asthma
10
Recruiting
SAS115359: A 6-month Study to Assess the Safety and Benefit of Inhaled Fluticasone Propionate/Salmeterol Combination Compared With Inhaled Fluticasone Propionate in the Treatment of Adolescents and Adults (12 Years of Age and Older) With Asthma.
Last Updated: May 10, 2012
Condition(s): Asthma
11
Completed
Fluticasone Propionate-salmeterol Combination Adherence in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Last Updated: March 15, 2012
Condition(s): Pulmonary Disease, Chronic Obstructive
12
Recruiting
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
Last Updated: May 10, 2012
Condition(s): Asthma
13
Completed
Chronic Obstructive Pulmonary Disease (COPD)-Related Outcomes and Costs for Patients on Combination Fluticasone Propionate-Salmeterol Xinafoate 250/50mcg Versus Anticholinergics in a COPD-Comorbid Depression/Anxiety Population
Last Updated: June 16, 2011
Condition(s): Pulmonary Disease, Chronic Obstructive
14
Completed
Chronic Obstructive Pulmonary Disease (COPD)-Related Healthcare Utilization and Costs After Discharge From a Hospitalization or Emergency Department Visit on a Regimen of Fluticasone Propionate-Salmeterol Combination Versus Other Maintenance Therapies
Last Updated: August 4, 2011
Condition(s): Pulmonary Disease, Chronic Obstructive
15
Completed
Outcomes for Medicare Asthma Patients Taking Fluticasone Propionate/Salmeterol Xinafoate Combination Versus Inhaled Corticosteroids or Other Combination Therapy
Last Updated: July 28, 2011
Condition(s): Asthma
16
Active, not recruiting
Chronic Obstructive Pulmonary Disease (COPD) Post-hospitalization Study
Last Updated: February 2, 2012
Condition(s): Pulmonary Disease, Chronic Obstructive; Chronic Obstructive Pulmonary Disease
17
Completed
A 24-Week Study to Evaluate the Safety and Efficacy of ADVAIR DISKUS 250/50mcg Plus SPIRIVA HANDIHALER Versus SPIRIVA HANDIHALER Plus Placebo DISKUS in Subjects With Chronic Obstructive Pulmonary Disease (COPD). SPIRIVA and HANDIHALER Are Trade Marks of Boehringer Ingelheim
Last Updated: May 17, 2012
Condition(s): Pulmonary Disease, Chronic Obstructive
18
Completed
A 12-Month Study Comparing Fluticasone Propionate/Salmeterol (ADVAIR) DISKUS Combination Product 250/50mcg Twice Daily To Fluticasone Propionate (FLOVENT) DISKUS 250 Mcg Twice Daily In Symptomatic Patients With Asthma
Last Updated: May 5, 2011
Condition(s): Asthma
19
Completed
A 12-Month Study Comparing Fluticasone Propionate/Salmeterol (ADVAIR) DISKUS Combination Product 250/50mcg BID To Fluticasone Propionate (FLOVENT) DISKUS 250 Mcg BID In Symptomatic Subjects With Asthma
Last Updated: November 10, 2011
Condition(s): Asthma
20
Completed
Impact of Initiating Tiotropium Alone Versus Initiating Tiotropium in Combination With Fluticasone Propionate/Salmeterol Xinafoate Combination (FSC) on Chronic Obstructive Pulmonary Disease-related Outcomes in Patients With Pre-existing Exacerbations
Last Updated: September 15, 2011
Condition(s): Pulmonary Disease, Chronic Obstructive

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Salmeterol+Fluticasone+propionate+combination

Page 1 of Clinical Trials for Salmeterol Fluticasone propionate combination, 140 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About